LOINC
Version 2.73

95356-2Revised Pretransplant Assessment of Mortality (PAM) Score panelActive

Term Description

Pretransplant Assessment of Mortality (PAM) Score assessment (revised) is used to estimate the probability of survival at 2 years after allogeneic hematopoietic stem cell transplantation with myeloablative conditioning for treatment of a hematologic malignancy.[PMID:25644959]
Source: Regenstrief LOINC

Panel Hierarchy
Details for each LOINC in Panel LHC-Forms

LOINC Name R/O/C Cardinality Example UCUM Units
95356-2 Revised Pretransplant Assessment of Mortality (PAM) Score panel
Indent46251-5 Patient Age
Indent3143-5 Donor relationship to patient
Indent96061-7 HLA donor match status [Type]
Indent96060-9 Disease
Indent33893-9 Disease subcategory
Indent67213-9 Disease stage
Indent20152-5 Percent of predicted forced expiratory volume in one-second (FEV1) %
Indent22239-8 Patient Cytomegalovirus (CMV) serology
Indent47430-4 Donor Cytomegalovirus (CMV) serology
Indent95357-0 Revised Pretransplant Assessment of Mortality (PAM) Total score {score}

Fully-Specified Name

Component
Pretransplant assessment of mortality score panel
Property
-
Time
Pt
System
^Patient
Scale
-
Method
PAM.Revised

Additional Names

Short Name
Revised PAM Score Pnl

Basic Attributes

Class
PANEL.CLIN.RISK
Type
Clinical
First Released
Version 2.68
Last Updated
Version 2.69
Order vs. Observation
Observation
Panel Type
Panel

LOINC FHIR® API Example - CodeSystem and Questionnaire Requests Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=95356-2 https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/95356-2